Philadelphia, PA – According to filings with the U.S. Securities and Exchange Commission, Allevi Inc. is raising $2,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Ricardo Solorzano played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Allevi Inc.

Allevi builds tools to design and engineer with life. Our 3D bioprinters and bioinks are used by leading researchers worldwide to find solutions to humanity’s most difficult problems – to cure disease, to test novel drugs, to eliminate the organ waiting list, to build with life. Founded in 2014, our mission is to make it easy to design and engineer 3D tissues. We created our desktop 3D bioprinter to be the most versatile, powerful and easy-to-use bioprinter on the market. Since our humble beginnings, we have grown to serve hundreds of labs in all corners of the world and have become leaders in the biofabrication revolution. Allevi 3D bioprinters, software, and bioinks print 3D living tissues one layer at a time.

To learn more about Allevi Inc., visit http://allevi3d.com/

Contact:
Ricardo Solorzano, Chief Executive Officer
929-525-5384
ricardo@allevi3d.com
https://www.linkedin.com/in/rdsolorzano/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved